Spred-2 deficiency exacerbates acetaminophen-induced hepatotoxicity in mice

Hiroshi Wakabayashi, Toshihiro Ito, Soichiro Fushimi, Yuki Nakashima, Jyunya Itakura, Liu Qiuying, Min Min Win, Sun Cuiming, Cao Chen, Miwa Sato, Megumi Mino, Tetsuya Ogino, Hirofumi Makino, Akihiko Yoshimura, Akihiro Matsukawa

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

MAPKs are involved in acetaminophen (APAP)-hepatotoxicity, but the regulatory mechanism remains unknown. Here, we explored the role of Spred-2 that negatively regulates Ras/ERK pathway in APAP-hepatotoxicity. Spred-2 knockout (KO) mice demonstrated exacerbated liver injury, an event that was associated with increased numbers of CD4 + T, CD8 + T and NK cells in the liver compared to the control. Levels of CXCL9/CXCL10 that attract and activate these cells were increased in Spred-2 KO-liver. Kupffer cells isolated from Spred-2 KO mice after APAP challenge expressed higher levels of CXCL9/CXCL10 than those from the control. Upon stimulation with APAP or IFNγ, naïve Kupffer cells from Spred-2 KO mice expressed higher levels of CXCL9/CXCL10. NK cell-depletion attenuated APAP-hepatotoxicity with lowered hepatic IFNγ and decreased numbers of not only NK cells but also CD4 + T and CD8 + T cells in the liver. These results suggest that Spred-2 negatively regulates APAP-hepatotoxicity under the control of Kupffer cells and NK cells.

Original languageEnglish
Pages (from-to)272-282
Number of pages11
JournalClinical Immunology
Volume144
Issue number3
DOIs
Publication statusPublished - 2012 Sep

Fingerprint

Acetaminophen
Natural Killer Cells
Kupffer Cells
Knockout Mice
Liver
T-Lymphocytes
MAP Kinase Signaling System
Wounds and Injuries

Keywords

  • Acetaminophen
  • Hepatotoxicity
  • Liver immunology
  • Signaling pathway
  • Toxicology

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Wakabayashi, H., Ito, T., Fushimi, S., Nakashima, Y., Itakura, J., Qiuying, L., ... Matsukawa, A. (2012). Spred-2 deficiency exacerbates acetaminophen-induced hepatotoxicity in mice. Clinical Immunology, 144(3), 272-282. https://doi.org/10.1016/j.clim.2012.07.002

Spred-2 deficiency exacerbates acetaminophen-induced hepatotoxicity in mice. / Wakabayashi, Hiroshi; Ito, Toshihiro; Fushimi, Soichiro; Nakashima, Yuki; Itakura, Jyunya; Qiuying, Liu; Win, Min Min; Cuiming, Sun; Chen, Cao; Sato, Miwa; Mino, Megumi; Ogino, Tetsuya; Makino, Hirofumi; Yoshimura, Akihiko; Matsukawa, Akihiro.

In: Clinical Immunology, Vol. 144, No. 3, 09.2012, p. 272-282.

Research output: Contribution to journalArticle

Wakabayashi, H, Ito, T, Fushimi, S, Nakashima, Y, Itakura, J, Qiuying, L, Win, MM, Cuiming, S, Chen, C, Sato, M, Mino, M, Ogino, T, Makino, H, Yoshimura, A & Matsukawa, A 2012, 'Spred-2 deficiency exacerbates acetaminophen-induced hepatotoxicity in mice', Clinical Immunology, vol. 144, no. 3, pp. 272-282. https://doi.org/10.1016/j.clim.2012.07.002
Wakabayashi H, Ito T, Fushimi S, Nakashima Y, Itakura J, Qiuying L et al. Spred-2 deficiency exacerbates acetaminophen-induced hepatotoxicity in mice. Clinical Immunology. 2012 Sep;144(3):272-282. https://doi.org/10.1016/j.clim.2012.07.002
Wakabayashi, Hiroshi ; Ito, Toshihiro ; Fushimi, Soichiro ; Nakashima, Yuki ; Itakura, Jyunya ; Qiuying, Liu ; Win, Min Min ; Cuiming, Sun ; Chen, Cao ; Sato, Miwa ; Mino, Megumi ; Ogino, Tetsuya ; Makino, Hirofumi ; Yoshimura, Akihiko ; Matsukawa, Akihiro. / Spred-2 deficiency exacerbates acetaminophen-induced hepatotoxicity in mice. In: Clinical Immunology. 2012 ; Vol. 144, No. 3. pp. 272-282.
@article{896530c24fc046dc92d74d7527136f5f,
title = "Spred-2 deficiency exacerbates acetaminophen-induced hepatotoxicity in mice",
abstract = "MAPKs are involved in acetaminophen (APAP)-hepatotoxicity, but the regulatory mechanism remains unknown. Here, we explored the role of Spred-2 that negatively regulates Ras/ERK pathway in APAP-hepatotoxicity. Spred-2 knockout (KO) mice demonstrated exacerbated liver injury, an event that was associated with increased numbers of CD4 + T, CD8 + T and NK cells in the liver compared to the control. Levels of CXCL9/CXCL10 that attract and activate these cells were increased in Spred-2 KO-liver. Kupffer cells isolated from Spred-2 KO mice after APAP challenge expressed higher levels of CXCL9/CXCL10 than those from the control. Upon stimulation with APAP or IFNγ, na{\"i}ve Kupffer cells from Spred-2 KO mice expressed higher levels of CXCL9/CXCL10. NK cell-depletion attenuated APAP-hepatotoxicity with lowered hepatic IFNγ and decreased numbers of not only NK cells but also CD4 + T and CD8 + T cells in the liver. These results suggest that Spred-2 negatively regulates APAP-hepatotoxicity under the control of Kupffer cells and NK cells.",
keywords = "Acetaminophen, Hepatotoxicity, Liver immunology, Signaling pathway, Toxicology",
author = "Hiroshi Wakabayashi and Toshihiro Ito and Soichiro Fushimi and Yuki Nakashima and Jyunya Itakura and Liu Qiuying and Win, {Min Min} and Sun Cuiming and Cao Chen and Miwa Sato and Megumi Mino and Tetsuya Ogino and Hirofumi Makino and Akihiko Yoshimura and Akihiro Matsukawa",
year = "2012",
month = "9",
doi = "10.1016/j.clim.2012.07.002",
language = "English",
volume = "144",
pages = "272--282",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Spred-2 deficiency exacerbates acetaminophen-induced hepatotoxicity in mice

AU - Wakabayashi, Hiroshi

AU - Ito, Toshihiro

AU - Fushimi, Soichiro

AU - Nakashima, Yuki

AU - Itakura, Jyunya

AU - Qiuying, Liu

AU - Win, Min Min

AU - Cuiming, Sun

AU - Chen, Cao

AU - Sato, Miwa

AU - Mino, Megumi

AU - Ogino, Tetsuya

AU - Makino, Hirofumi

AU - Yoshimura, Akihiko

AU - Matsukawa, Akihiro

PY - 2012/9

Y1 - 2012/9

N2 - MAPKs are involved in acetaminophen (APAP)-hepatotoxicity, but the regulatory mechanism remains unknown. Here, we explored the role of Spred-2 that negatively regulates Ras/ERK pathway in APAP-hepatotoxicity. Spred-2 knockout (KO) mice demonstrated exacerbated liver injury, an event that was associated with increased numbers of CD4 + T, CD8 + T and NK cells in the liver compared to the control. Levels of CXCL9/CXCL10 that attract and activate these cells were increased in Spred-2 KO-liver. Kupffer cells isolated from Spred-2 KO mice after APAP challenge expressed higher levels of CXCL9/CXCL10 than those from the control. Upon stimulation with APAP or IFNγ, naïve Kupffer cells from Spred-2 KO mice expressed higher levels of CXCL9/CXCL10. NK cell-depletion attenuated APAP-hepatotoxicity with lowered hepatic IFNγ and decreased numbers of not only NK cells but also CD4 + T and CD8 + T cells in the liver. These results suggest that Spred-2 negatively regulates APAP-hepatotoxicity under the control of Kupffer cells and NK cells.

AB - MAPKs are involved in acetaminophen (APAP)-hepatotoxicity, but the regulatory mechanism remains unknown. Here, we explored the role of Spred-2 that negatively regulates Ras/ERK pathway in APAP-hepatotoxicity. Spred-2 knockout (KO) mice demonstrated exacerbated liver injury, an event that was associated with increased numbers of CD4 + T, CD8 + T and NK cells in the liver compared to the control. Levels of CXCL9/CXCL10 that attract and activate these cells were increased in Spred-2 KO-liver. Kupffer cells isolated from Spred-2 KO mice after APAP challenge expressed higher levels of CXCL9/CXCL10 than those from the control. Upon stimulation with APAP or IFNγ, naïve Kupffer cells from Spred-2 KO mice expressed higher levels of CXCL9/CXCL10. NK cell-depletion attenuated APAP-hepatotoxicity with lowered hepatic IFNγ and decreased numbers of not only NK cells but also CD4 + T and CD8 + T cells in the liver. These results suggest that Spred-2 negatively regulates APAP-hepatotoxicity under the control of Kupffer cells and NK cells.

KW - Acetaminophen

KW - Hepatotoxicity

KW - Liver immunology

KW - Signaling pathway

KW - Toxicology

UR - http://www.scopus.com/inward/record.url?scp=84864526061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864526061&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2012.07.002

DO - 10.1016/j.clim.2012.07.002

M3 - Article

VL - 144

SP - 272

EP - 282

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 3

ER -